Floatz logo

ERIBULIN MONOMETHANESULFONATE

Stage IV Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
81/ 100

Competitive context

24 Active assets in the Stage IV Breast Cancer cohort.

Asset / SponsorPhaseRating
TRASTUZUMAB
SWOG Cancer Research Network
Phase 4BBB
Cyclophosphamide
UNC Lineberger Comprehensive Cancer Center
Phase 3BBB
Letrozole
OHSU Knight Cancer Institute
Phase 4BBB
Inno-206
Tanta University
Phase 3BBB
FILGRASTIM
Centre Georges Francois Leclerc
Phase 4BBB

View all 50 →

Same molecule, other indications

ERIBULIN MONOMETHANESULFONATE is also rated in:

breast neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
breast cancerDormant
BB
Indicative ·
69 / 100
View asset →
Metastatic Triple-Negative Breast CarcinomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →